David Roman
Stock Analyst at Goldman Sachs
(2.24)
# 2,822
Out of 5,043 analysts
52
Total ratings
46.67%
Success rate
-0.8%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Initiates: Sell | $64 | $72.85 | -12.15% | 1 | Oct 1, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $15.37 | +4.10% | 1 | Oct 1, 2025 | |
| GKOS Glaukos | Initiates: Buy | $103 | $75.68 | +36.10% | 1 | Oct 1, 2025 | |
| IRTC iRhythm Technologies | Maintains: Neutral | $158 → $180 | $182.71 | -1.48% | 3 | Oct 1, 2025 | |
| DOCS Doximity | Downgrades: Sell | $57 → $64 | $68.50 | -6.57% | 4 | Oct 1, 2025 | |
| BBNX Beta Bionics | Upgrades: Buy | $18 → $26 | $23.75 | +9.47% | 2 | Oct 1, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $20 | $12.31 | +62.47% | 1 | Aug 25, 2025 | |
| CARL Carlsmed | Initiates: Buy | $19 | $13.45 | +41.26% | 1 | Aug 18, 2025 | |
| OMDA Omada Health | Initiates: Buy | $29 | $26.42 | +9.77% | 1 | Jul 1, 2025 | |
| HQY HealthEquity | Maintains: Neutral | $94 → $104 | $96.17 | +8.14% | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $325.80 | +16.64% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $103.12 | +0.85% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $9.01 | +10.99% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $78.35 | +4.66% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $23 | $27.07 | -15.04% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $127.18 | +21.09% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $14.94 | +60.64% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $71.98 | -1.36% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $54.26 | +1.36% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $42 | $23.17 | +81.27% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $383.72 | +11.28% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $90 | $80.82 | +11.36% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $102.43 | -12.14% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $551.25 | -9.30% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $187.04 | +46.49% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $94.13 | -11.82% | 1 | May 30, 2024 |
The Cooper Companies
Oct 1, 2025
Initiates: Sell
Price Target: $64
Current: $72.85
Upside: -12.15%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $15.37
Upside: +4.10%
Glaukos
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $75.68
Upside: +36.10%
iRhythm Technologies
Oct 1, 2025
Maintains: Neutral
Price Target: $158 → $180
Current: $182.71
Upside: -1.48%
Doximity
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $68.50
Upside: -6.57%
Beta Bionics
Oct 1, 2025
Upgrades: Buy
Price Target: $18 → $26
Current: $23.75
Upside: +9.47%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $12.31
Upside: +62.47%
Carlsmed
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $13.45
Upside: +41.26%
Omada Health
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $26.42
Upside: +9.77%
HealthEquity
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $96.17
Upside: +8.14%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $325.80
Upside: +16.64%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $103.12
Upside: +0.85%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $9.01
Upside: +10.99%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $78.35
Upside: +4.66%
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $27.07
Upside: -15.04%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $127.18
Upside: +21.09%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $14.94
Upside: +60.64%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $71.98
Upside: -1.36%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $54.26
Upside: +1.36%
Feb 26, 2025
Reinstates: Buy
Price Target: $42
Current: $23.17
Upside: +81.27%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $383.72
Upside: +11.28%
Dec 5, 2024
Maintains: Buy
Price Target: $81 → $90
Current: $80.82
Upside: +11.36%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $102.43
Upside: -12.14%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $551.25
Upside: -9.30%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $187.04
Upside: +46.49%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $94.13
Upside: -11.82%